STRATA Skin Sciences, Inc. (SSKN)
Company Description
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.
The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions.
The company distributes its products internationally through distributors, and domestically directly to physicians.
The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016.
STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
| Country | United States |
| Founded | 1989 |
| IPO Date | Oct 28, 2005 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 115 |
| CEO | Dolev Rafaeli |
Contact Details
Address:
5 Walnut Grove Drive, Suite 140 Horsham, Pennsylvania 19044 United States | |
| Phone | 215-619-3200 |
| Website | strataskinsciences.com |
Stock Details
| Ticker Symbol | SSKN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001051514 |
| CUSIP Number | 86272A206 |
| ISIN Number | US86272A2069 |
| Employer ID | 13-3986004 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| William D. Humphries M.B.A. | Executive Chairman |
| Robert J. Moccia | President, Chief Executive Officer and Director |
| Christopher Lesovitz | Chief Financial Officer |
| Jay Sturm | General Counsel and Corporate Secretary |
| Keith Simeone | Vice President of Sales |
| Dr. Darrell S. Rigel | Chief Medical Advisor |
| Shmuel Gov | Executive Vice President and GM |
| Michael E. Goodman | Head of International Sales |
| Nikolai Kabelev | Vice President of Research & Development |
| Michael R. Stewart | Independent Consultant |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 13, 2023 | 8-K | Current Report |
| Feb 27, 2023 | 8-K | Current Report |
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 1, 2023 | 8-K | Current Report |
| Jan 9, 2023 | 8-K | Current Report |
| Jan 9, 2023 | 8-K | Current Report |
| Nov 9, 2022 | 10-Q | Quarterly Report |
| Nov 9, 2022 | 8-K | Current Report |
| Oct 28, 2022 | 8-K | Current Report |